Abstrakt

Bacterial Meningitis in The Setting of Critical COVID-19, Not Every Symptom is COVID

Jorge Fernandez-Tapia

 Despite advances in the understanding of its pathophysiology and clinical manifestations, COVID-19 continues to be an emerging disease with a wide clinical spectrum yet to be fully elucidated which is variable and ranges from asymptomatic infection to critical illness usually characterized by an acute respiratory distress syndrome resulting in hypoxic respiratory failure [1]. Yet, the fact that a high proportion of confirmed cases might not meet case definitions of either WHO or CDC can represent a challenge in the clinical setting when treating patients with a diverse arrange of symptoms and a positive COVID-19 test [2]. Neisseria meningitidis is a Gram-negative diplococcus identified to be the causative organism of meningococcal meningitis and is found in the human nasopharynx. Out of the 13 recognized serotypes 6 have been found to be pathogenic. Transmission of this pathogen occurs via droplets within approximately 1m and invasive disease among close and household contacts has been well established